Clinical Trials Insight: 700028968
Phase of Trial: Phase I/II
Latest Information Update: 12 Jan 2010
At a glance
- Drugs Glucagon-like peptide-1 (Primary)
- Indications Stroke
- Focus Adverse reactions
- Sponsors Biocompatibles International
- 12 Jan 2010 Completion of patient enrolment now expected in 2010. Six patients have been recruited and recruitment of the remaining 14 patients is expected by end of 2010, according to a Biocompatibles International media release.
- 30 Nov 2007 Completion of patient enrolment expected in 2008.
- 30 Nov 2007 New trial record.